Mark Cuban Keynotes Sold-Out Drug Channels Leadership Forum 2026 Featuring 340B Program Discussion

The second annual Drug Channels Leadership Forum (DCLF) took place in March 2026, drawing nearly 400 attendees for a sold-out event focused on critical discussions about the evolving drug channel landscape. Despite travel challenges, the forum featured dynamic exchanges, candid insights, and thought-provoking sessions, including a widely noted discussion on the 340B program. The event included contributions from industry leaders representing AstraZeneca, Boehringer Ingelheim, Cardinal Health, 46Brooklyn, Nephron Research, and Prime Therapeutics. Mark Cuban delivered a keynote address on U.S. healthcare during the first day of the forum.

The Drug Channels Institute team introduced seven members at the event, with two new team members—Tyler Novotny and Bryce Platt—moderating panels. The forum maintained exclusivity by not inviting media or recording sessions; attendees had to be present to access its content. Photos from the event can be found under #DCLF2026 on LinkedIn. Organizers announced that DCLF will return in March 2027.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: March 25, 2026

Author

GOAI